Conmed (CNMD) Operating Income (QoQ) (2010 - 2026)
Conmed (CNMD) Operating Income (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.08 Bn | 175.79 Bn | 6.27 Bn |
| 2 | Stryker | 128.71 Bn | 125.83 Bn | 3.81 Bn |
| 3 | Medtronic | 108.79 Bn | 99.57 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.41 Bn | 66.96 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn |
| 7 | Dexcom | 28.34 Bn | 27.22 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.87 Bn | 26.29 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn |
| 10 | Conmed | 1.33 Bn | 1.30 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.61% |
| Dec 31, 2025 | 208.31% |
| Sep 30, 2025 | -68.87% |
| Jun 30, 2025 | 139.13% |
| Mar 31, 2025 | -69.60% |
| Dec 31, 2024 | -20.10% |
| Sep 30, 2024 | 39.48% |
| Jun 30, 2024 | 34.54% |
| Mar 31, 2024 | -30.23% |
| Dec 31, 2023 | 65.63% |
| Sep 30, 2023 | 10.51% |
| Jun 30, 2023 | 115.91% |
| Mar 31, 2023 | 1,259.73% |
| Dec 31, 2022 | -104.52% |
| Sep 30, 2022 | -0.86% |
| Jun 30, 2022 | 8.97% |
| Mar 31, 2022 | -39.69% |
| Dec 31, 2021 | 39.33% |
| Sep 30, 2021 | 3.91% |
| Jun 30, 2021 | 28.01% |